Lakefront Biotherapeutics Income Statement (2014-2026) | LKFT

1Y3Y5Y7Y10YAll
Download Data
Income Statement Apr2014 Dec2014 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter)
0.17B0.37B0.26B0.02B0.02B0.03B0.18B0.06B0.07B0.07B0.12B0.07B-0.06B0.21B0.01B0.08B0.07B0.08B1.05B0.01B
Cost of Revenue (Quarter)
0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.01B0.02B0.00B-0.00B0.02B0.00B0.01B0.01B0.01B0.00B0.01B
Gross Profit (Quarter)
0.17B0.37B0.26B0.01B0.02B0.02B0.18B0.06B0.06B0.06B0.10B0.07B-0.05B0.19B0.01B0.06B0.07B0.07B1.05B0.00B
Operating items
Research & Development (Quarter)
-0.02B-0.03B0.38B-0.06B0.44B-0.08B0.06B-0.25B0.61B-0.19B0.19B-0.40B0.94B-0.04B
Selling, General & Administrative (Quarter)
-0.06B-0.04B0.24B-0.03B0.23B-0.03B0.03B-0.09B0.21B-0.04B0.04B-0.12B0.29B-0.04B
Restructuring Costs (Quarter)
Other Operating Expenses (Quarter)
0.02B0.04B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.05B-0.03B0.06B0.01B0.01B0.43B-1.36B0.00B
Operating Expenses (Quarter)
-0.24B-0.07B0.62B-0.06B-0.06B-0.06B-0.20B-0.08B-0.08B-0.10B-0.01B-0.19B-0.11B-0.09B-0.13B-0.07B
Operating Income (Quarter)
-0.06B-0.21B0.00B-0.02B-0.08B-0.04B0.00B-0.02B-0.01B-0.02B0.23B-0.04B0.11B-0.21B0.08B-0.17B0.18B-0.54B0.88B-0.07B
EBIT (Quarter)
-0.06B-0.21B0.00B-0.02B-0.08B-0.04B0.00B-0.02B-0.01B-0.02B0.23B-0.04B0.11B-0.21B0.08B-0.17B0.18B-0.54B0.88B-0.07B
Non-operating items
Interest & Investment Income (Quarter)
Other Non Operating Income (Quarter)
0.04B-0.00B-0.00B0.00B0.01B0.01B0.02B0.02B0.03B0.03B0.03B0.03B0.02B0.01B0.01B0.01B0.02B
Non Operating Income (Quarter)
0.02B0.06B-0.14B0.00B
Net income details
EBT (Quarter)
0.04B-0.21B0.00B-0.01B-0.08B-0.04B-0.06B-0.01B-0.01B-0.02B-0.05B0.02B0.05B-0.10B0.02B-0.16B0.18B-0.56B0.91B0.02B
Tax Provisions (Quarter)
0.00B0.00B0.00B-0.00B-0.00B-0.00B0.00B0.00B-0.01B0.00B-0.00B0.00B-0.00B0.00B-0.00B0.00B-0.00B0.02B-0.04B-0.00B
Profit After Tax (Quarter)
-0.08B-0.17B-0.06B-0.01B-0.02B0.02B-0.21B-0.01B0.00B0.05B0.19B0.10B-0.02B-0.02B-0.05B-0.16B0.17B-0.54B0.91B0.02B
Equity Income (Quarter)
0.02B0.10B
Investment Income (Quarter)
Income from Continuing Operations (Quarter)
0.04B-0.21B0.00B-0.01B-0.08B-0.04B-0.07B-0.01B-0.00B-0.02B-0.04B0.02B0.05B-0.10B0.02B-0.17B0.18B-0.59B0.96B0.02B
Income from Discontinued Operations (Quarter)
0.03B0.23B0.08B
Consolidated Net Income (Quarter)
0.04B-0.18B0.00B-0.01B-0.08B-0.04B-0.07B0.04B0.00B-0.02B0.21B0.07B0.00B-0.00B0.01B0.00B-0.00B0.00B-0.00B0.00B
Income towards Parent Company (Quarter)
-0.08B-0.18B-0.06B-0.01B-0.02B0.02B-0.21B0.02B0.01B0.03B0.17B0.10B0.01B-0.06B0.03B-0.16B-0.12B-0.24B0.91B0.02B
Net Income towards Common Stockholders (Quarter)
-0.08B-0.18B-0.06B-0.01B-0.02B0.02B-0.21B0.02B0.01B0.03B0.17B0.10B0.01B-0.06B0.03B-0.17B-0.12B-0.24B0.91B0.02B
Additional items
EPS (Basic) (Quarter)
-1.18-2.77-0.96-0.23-0.310.33-3.220.380.080.432.571.490.15-0.840.41-2.51-1.82-3.5913.820.24
EPS (Diluted) (Quarter)
-1.17-2.74-0.95-0.23-0.310.33-3.220.380.080.432.571.490.15-0.840.41-2.51-1.82-3.5913.820.24
Shares Outstanding (Quarter)
0.07B0.07B0.07B0.07B0.07B0.07B0.07B0.07B0.07B0.07B0.07B0.07B0.07B0.07B0.07B0.07B0.07B0.07B0.07B0.07B
Shares Outstanding (Diluted) (Quarter)
0.07B0.07B0.07B0.07B0.07B0.07B0.07B0.07B0.07B0.07B0.07B0.07B0.07B0.07B0.07B0.07B0.07B0.07B0.07B0.07B
EBITDA (Quarter)
-0.06B-0.21B0.00B-0.02B-0.08B-0.04B0.00B-0.02B-0.01B-0.02B0.23B-0.04B0.11B-0.21B0.08B-0.17B0.18B-0.54B0.88B-0.07B
Interest Expenses (Quarter)
-0.01B-0.00B0.02B-0.00B0.01B-0.00B0.00B-0.00B0.00B-0.00B0.00B-0.00B0.00B-0.00B
Tax Rate (Quarter)
2.01%-0.17%26.36%14.88%1.02%1.94%-6.01%-1.63%95.43%-3.81%4.91%2.48%-1.38%-1.94%-0.53%-1.16%-1.50%-4.11%-4.84%-0.50%